Kayano Kaori, Shimada Taketoshi, Shinomiya Takashi, Nakai Shigeru, Hisa Yasuo, Aoki Takanori, Seiki Motoharu, Okada Yasunori
Department of Otolaryngology, Kyoto Prefectural University of Medicine, Kyoto 602- 0841, Japan.
J Pathol. 2004 Apr;202(4):403-11. doi: 10.1002/path.1541.
Matrix metalloproteinases (MMPs), a family of extracellular matrix-degrading enzymes, are considered to play important roles in cancer invasion and metastasis. The present study examined the production levels of eight different MMPs (MMP-1, 2, 3, 7, 8, 9 and 13, and MT1-MMP) and two tissue inhibitors of metalloproteinases (TIMP-1 and 2) in homogenates of human salivary gland carcinomas [mucoepidermoid carcinomas (MECs), adenoid cystic carcinomas (ACCs), and adenocarcinomas (ADEs)] and non-neoplastic control salivary glands using sandwich enzyme immunoassay systems. The levels of MMP-1, MMP-2, MMP-13, MT1-MMP, and TIMP-1 were significantly higher in the carcinoma samples than in the controls (p < 0.05). Gelatin zymography demonstrated that the activation ratio of the MMP-2 zymogen (pro-MMP-2) was significantly higher in the carcinomas than in the controls (p < 0.05). In addition, the activation ratio in MECs was significantly higher than that in ACCs or ADEs (p < 0.01) and also correlated with histological grade and lymph node metastasis in MECs (p < 0.05), whereas the ratio showed no such correlation in ACCs or ADEs. Although the production levels of pro-MMP-2 and MT1-MMP were similar among these carcinoma groups, TIMP-2 levels were significantly higher in ACCs and ADEs than in MECs (p < 0.01). In carcinoma samples, the pro-MMP-2 activation ratio correlated directly with the MT1-MMP/TIMP-2 ratio (r = 0.736, n = 23; p < 0.01). Immunohistochemistry and in situ zymography demonstrated localization of MMP-2, MT1-MMP, and TIMP-2 to carcinoma cells, but only in MECs did carcinoma cell nests exhibit gelatinolytic activity, which was inhibited by 1,10-phenanthroline. These results suggest that enhanced activation of pro-MMP-2 mediated by MT1-MMP is implicated in the invasion and metastasis of MECs and that TIMP-2 may regulate pro-MMP-2 activation in salivary gland carcinomas.
基质金属蛋白酶(MMPs)是一族可降解细胞外基质的酶,被认为在癌症侵袭和转移中发挥重要作用。本研究使用夹心酶免疫分析系统检测了人涎腺癌[黏液表皮样癌(MECs)、腺样囊性癌(ACCs)和腺癌(ADEs)]及非肿瘤性对照涎腺匀浆中8种不同MMPs(MMP-1、2、3、7、8、9和13以及MT1-MMP)和2种金属蛋白酶组织抑制剂(TIMP-1和2)的产生水平。癌组织样本中MMP-1、MMP-2、MMP-13、MT1-MMP和TIMP-1的水平显著高于对照组(p<0.05)。明胶酶谱分析表明,癌组织中MMP-2酶原(pro-MMP-2)的激活率显著高于对照组(p<0.05)。此外,MECs中的激活率显著高于ACCs或ADEs(p<0.01),并且与MECs的组织学分级和淋巴结转移相关(p<0.05),而在ACCs或ADEs中该比率无此相关性。尽管这些癌组织组中pro-MMP-2和MT1-MMP的产生水平相似,但ACCs和ADEs中TIMP-2水平显著高于MECs(p<0.01)。在癌组织样本中,pro-MMP-2激活率与MT1-MMP/TIMP-2比率直接相关(r=0.736,n=23;p<0.01)。免疫组织化学和原位酶谱分析表明MMP-2、MT1-MMP和TIMP-2定位于癌细胞,但仅在MECs中癌细胞巢表现出明胶酶解活性,且该活性可被1,10-菲咯啉抑制。这些结果表明,MT1-MMP介导的pro-MMP-2激活增强与MECs的侵袭和转移有关,并且TIMP-2可能调节涎腺癌中pro-MMP-2的激活。